Tech Company Financing Transactions

Disco Pharmaceuticals Funding Round

Disco Pharmaceuticals, based in Cologne, secured $42 million from Ackermans & Van Haaren, NRW.BANK and AbbVie Biotech Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Gottfried-Hagen-Str. 60 -- 62
Cologne, 51105
Germany

Phone

Undisclosed

Website

www.discopharma.de

Email Address

[email protected]

Overview

At DISCO we are able to unlock the entire cancer cell surface at scale by identifying surface-bound proteins and uncovering protein communities. This approach thus permits unravelling comprehensive target information that neither standard proteomics, nor genome or transcriptome sequencing can provide.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Roman Thomas

        

Chief Operating Officer

Johannes Heuckmann

        

Chief Scientific Officer

Stefan Ries

        

Chief Technical Officer

Emanuela Tschudy-Milani

        

Browse more venture capital transactions:

Prev: 12/11/2025: Relation Therapeutics venture capital transaction
Next: 12/11/2025: Steelhead Technologies venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary